SSRI and Pregnancy: Safety, Risks & Benefits ACOG, CDC & NICE Guidelines 2026
Is it safe to take SSRIs like sertraline or escitalopram during pregnancy? Learn the latest evidence-based guidance from ACOG, CDC, NICE (UK), and experts on risks vs benefits of antidepressants in pregnancy, including neonatal adaptation and birth defects.
Expert advice by Naeem Mustafa, Pharmacist.SSRI and Pregnancy: Risks,Benefits, and Latest Guidelines (2026)
Depression and anxiety affect up to 1 in 5 women during pregnancy. For many in the USA, UK, and Australia, Selective Serotonin Reuptake Inhibitors (SSRIs) remain one of the most commonly prescribed treatments.
 |
SSRI and Pregnancy: Risks, Benefits & Safety Guidelines (ACOG, CDC & NICE 2026) |
A common question is: Are SSRIs safe during pregnancy?
The answer, according to major health authorities, is that for many women, the benefits of treating maternal mental illness often outweigh the small potential risks associated with these medications.Important: This article provides general information only. Never stop or start medication without consulting your doctor, obstetrician, or perinatal psychiatrist. Individual decisions must consider your personal medical history.
Written by: Naeem Mustafa, Pharmacist
Why Treating Depression and Anxiety in Pregnancy
Matters Untreated perinatal depression is linked to serious risks, including:Preterm birth and low birth weight
Preeclampsia
Poor prenatal care and nutrition
Substance use
Impaired mother-infant bonding
Increased risk of postpartum depression
In severe cases, suicidal thoughts or behaviors
Major organizations, including the American College of Obstetricians and Gynecologists (ACOG), emphasize that untreated maternal mental health conditions can have significant consequences for both mother and baby.
acog.org
What Do Leading Guidelines Say About SSRIs in Pregnancy?ACOG (USA, 2023–2025 updates): “Robust evidence has shown that SSRIs are safe in pregnancy and that most do not increase the risk of birth defects.” ACOG strongly recommends SSRIs as first-line pharmacotherapy for perinatal depression and anxiety when needed.
acog.org
CDC (USA): Through its “Treating for Two” initiative, the CDC has highlighted the importance of balancing medication safety with the risks of untreated illness and continues to support research into safer medication use in pregnancy.
cdc.gov
NICE (UK): The National Institute for Health and Care Excellence advises that antidepressants can be used during pregnancy if clinically indicated, particularly for moderate to severe depression. Psychological therapy should be considered first for milder cases, but medication should not be withheld when necessary.
cks.nice.org.uk
Society for Maternal-Fetal Medicine (SMFM, USA): Supports the use of SSRIs, noting that risks are generally small and often overshadowed by the dangers of untreated depression.
Similar balanced approaches are reflected in Australian guidelines (RANZCOG and beyond), which stress shared decision-making.Key Risks and Evidence Summary (2026 Update)Large studies involving hundreds of thousands of pregnancies show:Congenital Birth Defects
Most SSRIs do not substantially increase the overall risk of major birth defects. Earlier concerns about cardiac defects (particularly with paroxetine/Paxil) have been largely reassuring in more recent, better-controlled data. ACOG states that most SSRIs do not increase this risk.
acog.org
Preterm Birth & Low Birth Weight
There is a modest association in some studies, but when compared to women with untreated depression, the risk often appears similar or even lower with effective treatment.Neonatal Adaptation Syndrome (Poor Neonatal Adaptation)
Up to 25–30% of babies exposed to SSRIs in late pregnancy may show temporary symptoms such as jitteriness, irritability, feeding difficulties, or mild breathing issues.These are usually mild, self-limiting, and resolve within days to two weeks.
Persistent Pulmonary Hypertension of the Newborn (PPHN)
The absolute risk remains very low (typically <1–2 per 1,000 births), even if a small increase has been observed in some studies.
Neurodevelopmental Outcomes (Autism, ADHD, IQ)
After adjusting for maternal depression and other factors, large studies generally do not show a clear causal link between SSRI exposure and long-term developmental problems.Other Considerations
Slight increases in risk for gestational hypertension or postpartum hemorrhage have been noted in some data, but these are generally small and manageable with monitoring.Which SSRIs Are Often Preferred?
According to ACOG and clinical practice:Sertraline (Zoloft) and Escitalopram (Lexapro) are frequently considered reasonable first-line options due to extensive safety data.
Fluoxetine (Prozac) also has a long history of use.
Paroxetine (Paxil) is often avoided or used with extra caution because of older data on possible cardiac risks.
If you are stable and doing well on a particular SSRI, many specialists advise against switching just because of pregnancy, as the risk of relapse can be high.Shared Decision-Making:
What Should You Discuss with Your Doctor?
Your healthcare team will consider:Severity of your depression or anxiety
Your previous response to medication
Non-drug options (CBT, interpersonal therapy, lifestyle support)
Your personal values and preferences
Never stop SSRIs suddenly
This can cause withdrawal symptoms and increase the chance of relapse, which may harm both you and your baby.Practical Monitoring Tips (USA, UK, Australia) Regular prenatal visits with monitoring of fetal growth, blood pressure, and glucose.
Pediatric teams may be informed in late pregnancy to watch for mild neonatal adaptation symptoms.
Breastfeeding is often compatible with SSRIs (sertraline usually has the lowest transfer into breast milk).
Strong postpartum mental health support is essential.
For Women in the USA, UK & Australia Major authorities including ACOG, CDC, NICE, and SMFM agree:
When clinically indicated, SSRIs can be an important, evidence-based treatment option during pregnancy.
The risks of medication are generally small compared to the well-documented harms of untreated perinatal mental illness.
By Naeem Mustafa, Pharmacist
At PharmaServePK, We are committed to providing clear, up-to-date, evidence-based information to help patients and families make informed decisions together with their healthcare providers.Medical
Disclaimer:
This article is for educational purposes only and is not a substitute for professional medical advice.
Always consult your doctor, obstetrician, psychiatrist, or perinatal mental health specialist before making any changes to your medication.
Guidelines continue to evolve with new research.
References & Further Reading:ACOG Clinical Practice Guideline No. 5 (2023) and 2025 Statement on SSRIs
CDC Treating for Two Initiative
NICE Guideline CG192: Antenatal and Postnatal Mental Health
SMFM Statements on SSRIs and Pregnancy (2025).
No comments:
Post a Comment